These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8250072)

  • 1. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
    Helm CJ; Holland GN; Lin R; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1993 Dec; 116(6):700-7. PubMed ID: 8250072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model.
    Hu FR; Wang IJ
    Curr Eye Res; 1998 May; 17(5):478-82. PubMed ID: 9617541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
    Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis.
    Hyon JY; Joo MJ; Hose S; Sinha D; Dick JD; O'Brien TP
    Arch Ophthalmol; 2004 Aug; 122(8):1166-9. PubMed ID: 15302657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
    Hu FR; Luh KT
    Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium fortuitum keratitis. A comparison of topical ciprofloxacin and amikacin in an animal model.
    Stevens RK; Holland GN; Paschal JF; Phinney RB; Berlin OG; Bruckner DA
    Cornea; 1992 Nov; 11(6):500-4. PubMed ID: 1468211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Mycobacterium chelonae keratitis with amikacin, doxycycline and topical ciprofloxacin.
    Probst LE; Brewer LV; Hussain Z; Tokarewicz AC
    Can J Ophthalmol; 1994 Apr; 29(2):81-4. PubMed ID: 8069760
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis.
    Giaconi J; Pham R; Ta CN
    J Cataract Refract Surg; 2002 May; 28(5):887-90. PubMed ID: 11978473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit Streptococcus pneumoniae keratitis model and topical therapy.
    Guzek JP; Cline DJ; Row PK; Wessels IF; Beeve S; Ispirescu S; Aprecio RM; Kettering JD; Gano DL; Nelson GM
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2012-7. PubMed ID: 9761279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone.
    Hamam RN; Noureddin B; Salti HI; Haddad R; Khoury JM
    Ophthalmology; 2006 Jun; 113(6):950-4. PubMed ID: 16647126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
    Shih MH; Huang FC
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Mycobacterium chelonae keratitis following LASIK.
    Verma S; Watson SL; Dart JK; Eykyn SJ
    J Refract Surg; 2003; 19(3):379-80. PubMed ID: 12777038
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
    Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
    Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
    Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R; Cockrum P; Crider J; Schlech B
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.
    Hobden JA; O'Callaghan RJ; Hill JM; Hagenah M; Insler MS; Reidy JJ
    Curr Eye Res; 1992 Mar; 11(3):259-65. PubMed ID: 1587148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium keratitis after laser in situ keratomileusis.
    Gelender H; Carter HL; Bowman B; Beebe WE; Walters GR
    J Refract Surg; 2000; 16(2):191-5. PubMed ID: 10766389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.